Question 1

Does Medicare cover Wegovy?

Accepted Answer

Medicare Part D covers Wegovy only when prescribed for cardiovascular risk reduction (post-2024 CMS guidance), not for obesity alone.

Question 2

Does Medicare cover Ozempic for weight loss?

Accepted Answer

Covered under Medicare Part D for type 2 diabetes diagnosis. For weight-loss-only use without a diabetes diagnosis, Medicare typically does not cover Ozempic, since the drug is FDA-approved only for type 2 diabetes (Wegovy is the obesity-indicated semaglutide).

Question 3

Does Medicare cover Zepbound?

Accepted Answer

Not covered for weight loss. Federal law prohibits Medicare from covering anti-obesity medications without separate Congressional action.

Question 4

Does Medicare cover Mounjaro?

Accepted Answer

Covered under Medicare Part D for type 2 diabetes diagnosis.

Question 5

What's the copay for GLP-1 medications with Medicare?

Accepted Answer

When Medicare does cover a GLP-1, the typical patient copay is $30–$100 per month. Prior authorization is almost always required, and many plans also require step therapy through metformin or another diabetes medication first.

Question 6

How do I appeal a Medicare GLP-1 denial?

Accepted Answer

If Medicare denies your GLP-1 prescription, you have the right to appeal. Steps: (1) request the written denial letter and the specific clinical criteria, (2) ask your prescriber to submit a Letter of Medical Necessity citing BMI, comorbidities, and prior failed weight-loss attempts, (3) file a formal appeal within the deadline (usually 60-180 days), (4) escalate to an external review if denied again. Many denials are overturned on appeal with proper documentation.

Question 7

What if I can't get Medicare to cover GLP-1?

Accepted Answer

If your appeal is denied, the most affordable cash-pay option is compounded semaglutide or tirzepatide through telehealth providers. Monthly costs typically range from $149-$299 for compounded GLP-1s versus $1,000-$1,350 for brand-name medications. Top providers serving denied patients include Hims, Ro, Found.

Medication	Medicare Coverage
Wegovy (semaglutide)	Medicare Part D covers Wegovy only when prescribed for cardiovascular risk reduction (post-2024 CMS guidance), not for obesity alone.
Ozempic (semaglutide)	Covered under Medicare Part D for type 2 diabetes diagnosis.
Zepbound (tirzepatide)	Not covered for weight loss. Federal law prohibits Medicare from covering anti-obesity medications without separate Congressional action.
Mounjaro (tirzepatide)	Covered under Medicare Part D for type 2 diabetes diagnosis.
Typical copay (when covered)	$30–$100 / month

Does Medicare Cover GLP-1 Medications? (2026)

Coverage by Medication

If You're Denied by Medicare

Top Compounded Alternatives

BistroMD

Boston Medical Group

Found

Hims

Lean Hybrid Protein

Ro

Rx Pros Health

Frequently Asked Questions

Medicare Coverage Updates